next several years, he worked, among other things, doing research related to enkephalins.
In 1979, Dr. Mullis was hired by the Cetus Corporation to synthesize oligonucleotide probes, which he enjoyed very much. But, by 1983, as Mullis states, "the charm had dissappeared." Automation could now do the job faster and more efficiently. It was, as he states, a period in his life where "there was a fair amount of time available to think and putter."
The thinking that conceived the polymerase chain reaction (PCR) technique was realized during a night drive through northern California's redwood country mountains in the spring of 1983. He was trying to devise a method that would find a specific sequence or fragment of a DNA molecule and then be able to amplify it at least a billion-fold in order to readily allow its detection and identification. He then realized that the duplication/amplification could be achieved by using a DNA polymerase and that this amplification would proceed exponentially. He could rapidly produce a billion molecules with just about 30 of these amplification cycles.
He also realized that by using a DNA polymerase, the assay would be extremely specific. He mentions that he actually thought then, that if this worked, he could "win a Nobel Prize." Almost all of his close scientific associates either discounted the concept or failed to see any practical applications. In spite of this, Dr. Mullis worked diligently and by December 1983 he had created a three-step assay that 1) thermally denatured and separated strands of the target DNA by heating it; 2) cooled the mixture and then would use a known sequence DNA strand to search for, and hybridize to, its complementary partner in the unknown sample (annealing of the primers to the target DNA strand); and 3) amplify the target/ primer segments of DNA with polymerase, which duplicated the DNA sample exponentially with each step or cycle.
Having to add fresh polymerase for each cycle became an initial hindrance. Once a thermostable DNA polymerase was incorporated into the procedure, the process became much faster and simpler. This thermostable (Taq polymerase) was a pivotal modification, which was possible as a result of a prior discovery by microbiologist Thomas Brock of the thermophile bacteria Thermus aquaticus from which this thermostable polymerase was first extracted.
Dr. Mullis submitted a paper outlining his invention to Nature and Science. Both of these journals rejected his paper. Science went on to say that the paper could "be published in some secondary journal," since they felt that "it would not be suitable to meet the needs of their readers." However, Dr. James Watson (Nobel laureate for the discovery of the molecular structure of DNA) became aware of his work and immediately appreciated its significance and foresaw its potential. Dr. Mullis was invited to present his work at the 1986 Cold Spring Harbor symposium. This would become the first announcement of the PCR technique at a public meeting and its first announcement to the scientific world. It was then published in the symposia proceedings for that year. Dr. Mullis submitted his paper for official journal publication to the journal Methods in Enzymology. This time it was accepted and published.
After getting its well-deserved exposure, some very capable molecular biologists realized the simplicity of the concept and openly lamented and regretted that they had failed to stumble on it themselves. The PCR technique then took off and seemed to work its way into many applications. Investigators were finding endless applications for it.
At this juncture, his invention provoked a paradigm shift. His was a radically new concept and idea that could take a single DNA molecule, segment, or gene, and after about 30 amplification cycles, it could yield about a billion copies of that same DNA target sequence. The analytical beauty of the discovery laid in its ability to amplify a DNA sample rapidly, specifically, predictably, and effectively.
The PCR technique had revolutionized molecular diagnostics and opened up a new and almost limitless frontier of possible applications. This technique now allowed laboratory scientists to detect infection much earlier and independent of any serological response to the infectious agent. Moreover, infectious agents could now be detected even if present in very minute amounts or only in a few cells. In addition, infectious agents that were hitherto unculturable could now be detected, and in the field of genetics, DNA sequences implicated in various genetic disorders could also now be labmedicine.com detected. Practically all of the major viral and bacterial pathogens are now easily and rapidly identified by PCR. PCR has even found a niche in the rapid identification of bioterrorism agents. It has also led to the capability to detect RNA and is now priceless as a tool for measuring human immunodeficiency virus (HIV) viral load down to extremely low copy numbers. It has become an essential tool in the management and follow up of HIV-infected patients. It is also used in the screening of blood for infectious agents.
The automation of the PCR technique with thermal cyclers has advanced its use in a variety of applications, increased its efficiency, and shortened assay time. Forensic laboratory science has been revolutionized by the application of the PCR technique, and PCR has even been used in molecular paleontology and the study of fossil DNA. Sequencing of the human genome and many animal and microbial species relied on PCR for its success. More recently, an assay adaptation has linked PCR with the enzyme-linked immunosorbent assay (ELISA) technology to produce ultrasensitive assays that now reach into the realm of antigen-protein detection, which was previously impossible with PCR alone. This will open a whole new frontier of applications and increase its analytical sensitivity even more. PCR's impact on the medical laboratory and on molecular biology is truly incalculable and it appears that more applications are waiting to be discovered.
The Nobel Prize Committee took note of the PCR phenomenon early on. It thought it worthy of recognition when it awarded the 1993 Nobel Prize in Chemistry to Dr. Mullis. Thus, his seminal contribution to molecular biology and laboratory medicine was finally recognized.
This well-deserved luminary discovered an assay that was at first discounted and rejected by two prestigious journals.
Some in the scientific world did take note and the discovery soon flourished and found applications in countless areas of the medical laboratory. It can truly be said that Dr. Mullis has given an evolving tool that still today continues to yield new and important applications. His assay has impacted several of the medical laboratory disciplines including clinical chemistry, bacteriology, virology, and pharmacogenomics.
In 1989, the journal Science (which ironically rejected his PCR paper back in 1986) decided to award PCR its "molecule of the year" honors and DNA amplification was selected as the "major scientific development of 1989."
